Works matching IS 0008543X AND DT 2006 AND VI 106 AND IP 8


Results: 31
    1
    2
    3
    4
    6
    7
    8
    9

    Author reply.

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 8, p. 1864
    By:
    • Elena B. Elkin;
    • Clifford Hudis;
    • Colin B. Begg;
    • Deborah Schrag
    Publication type:
    Article
    10
    11
    13
    14
    15
    16
    18
    19
    21

    Decitabine improves patient outcomes in myelodysplastic syndromesSee related editorial on pages 1650‐2 and accompanying article on pages 1744‐50, this issue.: Results of a phase III randomized study.

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 8, p. 1794
    By:
    • Hagop Kantarjian;
    • Jean‐Pierre J. Issa;
    • Craig S. Rosenfeld;
    • John M. Bennett;
    • Maher Albitar;
    • John DiPersio;
    • Virginia Klimek;
    • James Slack;
    • Carlos de Castro;
    • Farhad Ravandi;
    • Richard Helmer;
    • Lanlan Shen;
    • Stephen D. Nimer;
    • Richard Leavitt;
    • Azra Raza;
    • Hussain Saba
    Publication type:
    Article
    22
    23

    Breast cancer in octogenarians.

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 8, p. 1664
    By:
    • Ella Evron;
    • Hadassah Goldberg;
    • Alexander Kuzmin;
    • Roee Gutman;
    • Shulamith Rizel;
    • Avishy Sella;
    • Haim Gutman
    Publication type:
    Article
    24
    25
    26
    27

    Vascular endothelial growth factor, FLT‐1, and FLK‐1 analysis in a pancreatic cancer tissue microarrayPresented as a poster at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium, Hollywood, Florida, January 27‐29, 2005.

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 8, p. 1677
    By:
    • Gina G. Chung;
    • Harry H. Yoon;
    • Maciej P. Zerkowski;
    • Sriparna Ghosh;
    • Laurie Thomas;
    • Malini Harigopal;
    • Lori A. Charette;
    • Ronald R. Salem;
    • Robert L. Camp;
    • David L. Rimm;
    • Barbara A. Burtness
    Publication type:
    Article
    28
    29

    High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high‐risk ewing sarcoma family tumors: The Bambino Gesù Children's Hospital experience

    Published in:
    Cancer (0008543X), 2006, v. 106, n. 8, p. 1838
    By:
    • Giuseppe Maria Milano;
    • Raffaele Cozza;
    • Ilaria Ilari;
    • Luigi De Sio;
    • Renata Boldrini;
    • Alessandro Jenkner;
    • Maretta De Ioris;
    • Alessandro Inserra;
    • Carlo Dominici;
    • Alberto Donfrancesco
    Publication type:
    Article
    30
    31